What move does the options market price into Biocryst Pharmaceuticals's report?

Implied ±39.7%, either direction · provisional.

How often does Biocryst Pharmaceuticals move more than the options market prices?

1 of the last 8 reports moved at least as far as the implied move.

BCRXNasdaqBiological Products, (No Diagnostic Substances)

Biocryst Pharmaceuticals Inc (BCRX) earnings date, market-implied expected move, and options open interest by expiry

8.32

Closed19:01 ET

Open8.80Volume10.2MMkt cap$2.1BEPS-1.34

Day8.15 – 8.8026%52-wk6.23 – 11.2242%

BCRX

Biocryst Pharmaceuticals Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±39.7%implied · straddle

4.9711.51

spot 8.24exp Mar 19ATM strike 8ATM straddle 3.85IV 100%

Nov 4 closeprovisional

Expected move

Inputs

Next report

Feb 25

before open · in 112 days

est.Q4 FY26

Calendar

Next report

Last report

−3.85%

vs ±13.1% implied · ×0.29

shaded = implied · ▲▼ = realized

Nov 4 '26 · confirmed

Implied vs realized

Largest filed tie

—

13F top-10 QoQ

+7.45%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

318 managers

Top fund weight

0.89%

BCRX weight · XBI

N-PORTJun 30 '26

5 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Biocryst Pharmaceuticals (BCRX) is expected to report on Feb 25 before open (estimated date).

Implied vs realized

8 reports

1 of 8≥ implied

avg implied: ±11.8%
avg realized: ±5.1%

Aug 4 '25Aug 4 '25confirmed±24.6%▲+9.81%×0.40

Oct 14 '25Oct 14 '25confirmed±8.6%▼−8.81%×1.02

Nov 3 '25Nov 3 '25confirmed±14.2%▼−6.28%×0.44

Jan 12 '26Jan 12 '26confirmed±7.9%▼−4.80%×0.61

Q1 FY26Feb 26 '26confirmed±7.0%▲+4.64%×0.66

May 6 '26May 6 '26confirmed±8.9%▼−2.21%×0.25

Q2 FY26Aug 5 '26confirmed±10.0%▲+0.55%×0.05

Nov 4 '26Nov 4 '26confirmed±13.1%▼−3.85%×0.29

quarterimplied−25%0+25%realized×

Nov '26±13.1%▼−3.85%×0.29

Q2 FY26±10.0%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 5 expiries · Nov 4 close

0.09OI · 5 expiries · Nov 4 closeP/C open interest · Mar 19 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

339+1%Nov 2015d0.056,432+1%0.05

1,4720%Dec 1843d0.217,1730%0.21

2,5330%Jan 1571d0.1122,3100%0.11

report · Feb 25 · before open · est.

890%Mar 19134d1,0170%

530%Apr 16162d0.077920%0.07

ExpiryPutsCallsP/C

Nov 2015d339+1%6,432+1%0.05

Dec 1843d1,4720%7,1730%0.21

Jan 1571d2,5330%22,3100%0.11

report · Feb 25 · before open · est.

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±39.7%

Funds 4

XBI±0.4%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod 1 more fund Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ3 FY26

21.03%as filednet margin · revenue −17.39% QoQ · +13.11% YoY

Revenue

$180M−17.39% QoQ

Gross profit

$179M−16.65% QoQ

99.13% margin

Operating income

$53M−45.84% QoQ

29.58% margin

Pre-tax income

$39M−51.45% QoQ

Net income

$38M−51.63% QoQ

21.03% margin

Cost of revenue

$2M−59.01% QoQ

Operating expenses

$125M+8.14% QoQ

SG&A $67M

R&D $58M

Other expense

$15M

Tax

$669,000−38.00% QoQ

Revenue$180M−17.39%

Gross profit

$179M−16.65%

99.13% margin

Operating income

$53M−45.84%

29.58% margin

Pre-tax income

$39M−51.45%

Net income

$38M−51.63%

21.03% margin

Cost of revenue

$2M−59.01%

Operating expenses

$125M+8.14%

SG&A $67M

R&D $58M

Other expense

$15M

Tax$669,000−38.00%

flow · deduction · signed % = QoQSource: SEC filings · standardized · QE Sep 30 '26 · width = $

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 4 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 19:00 ET

Intraday

Event sensitivity

PPI ×1.83· ±4.5% vs ±2.5% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±4.5%5 of 10×1.83

CPIconsumer prices±2.4%3 of 10×0.98

FOMCrate decision±2.1%12 of 24×0.85

NFPjobs report±1.8%4 of 10×0.71

PCEpersonal income & outlays±1.4%7 of 19×0.58

GDPgross domestic product±1.4%8 of 19×0.57

CPROFcorporate profits±0.9%5 of 12×0.37

Bar = avg |move| to ±5% · tick = ±2.5% avg day · ×base = |move| ÷ ±2.5% · min 6 releases

Earnings history

EPS 0.14 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	—	0.14	—
Q2 FY26	Aug 5 '26 · confirmed	0.30	—
Q1 FY26	Feb 26 '26 · confirmed	-2.98	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod